AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$AXON

Kalinowski Caitlin Elizabeth sold $77K of AXON

Kalinowski Caitlin Elizabeth sold 160 shares of AXON ENTERPRISE, INC. (AXON) at $482.93 on 2026-06-01.

Original reporting
SEC EDGAR · Kalinowski Caitlin Elizabeth
Published Jun 2, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

This adds incremental sentiment information for AXON but does not introduce new company fundamentals (earnings, guidance, contracts, litigation, or product/drug trial results).

02

Market read

Use as a small sentiment/positioning input; treat as low-impact unless corroborated by broader insider selling trends or other catalysts.

03

What to watch

No 10b5-1 plan is stated, but Form 4s can still reflect pre-planned schedules or personal needs; traders should check for prior insider transactions and overall insider net activity.

Relevance 4/10Novelty 6/10Timing: After-hours/next-session read-through from a newly filed Form 4 (filed 2026-06-02).

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise (AXON), reporting an open-market sale by a director.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon Enterprise director Caitlin Kalinowski sold 160 shares in an open-market transaction disclosed via SEC Form 4 on 2026-06-01.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment/positioning rather than fundamentals.

Evidence & confidence

The filing provides a discrete sale size and price but no accompanying company-specific operational or financial change.

Market effects

Sector

Minimal; this is company-specific insider activity with no sector-wide policy or regulatory change mentioned.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Director selling can be routine liquidity management; without evidence of a pattern or linkage to performance, the market may discount it quickly.

Key entities

  • issuer
    AXON ENTERPRISE, INC.

    Public company whose director insider sale is disclosed on SEC Form 4.

  • director
    Caitlin Elizabeth Kalinowski

    Director who sold 160 shares at $482.93/share on 2026-06-01.

Read at source← All news

Related articles

AUG 7
$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

aol.com4 min
AUG 6
$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

fool.com6 min
AUG 5
$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

benzinga.com2 min
AUG 5
$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

investing.com3 min
AUG 5
$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12

SEC EDGAR 8-K6 min